Over 15 years of ELTEC: A report of the international BFM study group

Pediatric Blood and Cancer

Volumn 49, Issue 1, 2007, Pages 113-114

  Paulides, M ^a   Haupt, R ^b   Jankovic, M ^c   Moricke A ^d   Langer, T ^a   Beck, J D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b G GASLINI INSTITUTE   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CHILDHOOD CANCER; CONFERENCE PAPER; HUMAN; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; HEPATITIS C; HUMANS; LEUKEMIA;

EID: 34249809147     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21087     Document Type: Conference Paper

References (11)

1. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: Future directions for clinical care and research. Pediatr Blood Cancer 2006;46:143-148.
2. Jankovic M, Reciputo A, Haupt R, et al. ELTEC: Ten years of activity (1990-2000) - A report of the International BFM Study Group. Med Pediatr Oncol 2002;38:124.
3. Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2006; [Epub ahead of print].
4. Langer T, Stohr W, Bielack S, et al. Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 2004;42:373-379.
5. Paulides M, Kremers A, Stohr W, et al. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS). Pediatr Blood Cancer 2006;46:489-495.
6. Stohr W, Patzer L, Paulides M, et al. Growth impairment after ifosfamide-induced nephrotoxicity in children. Pediatr Blood Cancer 2006; [Epub ahead of print].
7. Stohr W, Paulides M, Bielack S, et al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system. Pediatr Blood Cancer 2006; [Epub ahead of print].
8. Stohr W, Paulides M, Bielack S, et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: A report from the Late Effects Surveillance System. Pediatr Blood Cancer 2006; [Epub ahead of print].
9. Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: A 13-year experience at a single Italian institution. Eur J Cancer 2005;41:1439-1445.
10. Castellino S, Lensing S, Riely C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: An update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 2004;103:2460-2466.
11. Paulides M, Stohr W, Bielack S, et al. Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment in paediatric sarcoma patients: A report from the Late Effects Surveillance System. Oncol Rep 2006;15:687-691.